Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Completed

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Aarhus, Denmark
  • Novartis Investigative Site Copenhagen, Denmark
View all 15 locations
View Trial Details
Completed

Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis

NCT02473965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • University of California-Irvine Orange, California, United States
  • Yale University School of Medicine, Department of Neurology New Haven, Connecticut, United States
  • University of Florida at Shands Jacksonville Jacksonville, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 39 locations
View Trial Details
Completed

BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

NCT02110706

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California - Davis Davis, California, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • University of Colorado - Denver Denver, Colorado, United States
View all 26 locations
View Trial Details
Completed

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

NCT02301624

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Orange, California, United States
  • Palo Alto, California, United States
View all 60 locations
View Trial Details

Related conditions